Guardian Pharmacy Services, Inc. 8-K

What Happened

• Guardian Pharmacy Services, Inc. (GRDN) filed an 8-K on May 7, 2026 reporting final voting results from its Annual Meeting held May 5, 2026. The company elected its two Class II director nominees, approved the non‑binding advisory vote on executive compensation, chose a one‑year frequency for future advisory votes on pay, and ratified Ernst & Young LLP as its independent auditor.

Key Details

• Director elections (terms through 2029):
  • John Ackerman: For 44,674,937; Withhold 9,584,243; Broker non‑votes 909,843.
  • Randall Lewis: For 44,821,861; Withhold 9,437,319; Broker non‑votes 909,843.
• Say‑on‑pay (non‑binding): For 53,758,195; Against 500,207; Abstain 778; Broker non‑votes 909,843.
• Say‑on‑pay frequency: One‑year selected — 1 year: 52,068,050; 2 years: 462,404; 3 years: 1,728,539; Abstain 187. Company will hold annual advisory votes on executive compensation.
• Auditor ratification: Ernst & Young LLP ratified for 2026 — For 55,073,124; Against 91,887; Abstain 4,012.

Why It Matters

• These results confirm the company’s board lineup for the Class II seats through the 2029 annual meeting and show strong shareholder support for management’s approach to executive pay (non‑binding).
• Choosing annual say‑on‑pay votes gives shareholders a yearly opportunity to express views on compensation.
• Ratification of Ernst & Young LLP provides continuity in external audit oversight for 2026.
• Investors tracking corporate governance, board stability, or auditor relationships may view these outcomes as relevant when assessing company oversight and shareholder engagement.